This is where you will find financial information about Promore Pharma. You can download annual reports, quarterly reports and presentations and subscribe to our press releases and reports.
It is our ambition to provide the capital market, investors, shareholders and other stakeholders with relevant information to facilitate a fair valuation of the company and our external contacts. We strive to be as transparent as possible in all our actions. Do not hesitate to contact us if you require additional information.
- Promore Pharma has enrolled first patient in HEAL LL-37 in Poland
- Promore Pharma has conducted Investigator Meeting for HEAL LL-37 in Poland
- Promore Pharma Plans to Expand Indications of Therapeutic Peptide PXL01 in the Field of Dermal Scarring
- Promore Pharma receives approval for Phase IIb trial with LL-37 in Poland